Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 479.32M | 502.00M | 529.25M | 675.52M | 595.02M |
Gross Profit | 123.60M | 136.87M | 101.40M | 144.89M | 154.71M |
EBITDA | 4.78M | 40.49M | -14.06M | -4.54M | -116.52M |
Net Income | 8.04M | 5.26M | -54.04M | -46.40M | -173.05M |
Balance Sheet | |||||
Total Assets | 880.14M | 776.42M | 659.23M | 677.98M | 657.40M |
Cash, Cash Equivalents and Short-Term Investments | 312.05M | 271.57M | 252.21M | 146.80M | 167.66M |
Total Debt | 86.60M | 26.75M | 51.08M | 61.20M | 70.19M |
Total Liabilities | 343.25M | 287.69M | 297.22M | 311.98M | 361.47M |
Stockholders Equity | 536.53M | 486.66M | 359.86M | 365.88M | 295.46M |
Cash Flow | |||||
Free Cash Flow | -75.67M | -132.09M | 99.60M | -122.55M | -45.85M |
Operating Cash Flow | -73.19M | -129.29M | 107.55M | -100.45M | -15.04M |
Investing Cash Flow | 49.83M | 39.98M | -547.00K | 3.31M | -96.19M |
Financing Cash Flow | 66.31M | 101.84M | 2.20M | 74.19M | 35.17M |
China Energy Storage Technology Development Limited reported its unaudited consolidated interim results for the first half of 2025, revealing a significant decline in revenue and profit compared to the same period in 2024. The company experienced a net loss of HK$16.5 million, attributed to decreased revenue and increased finance costs, which may impact its market position and stakeholder confidence.
The most recent analyst rating on (HK:1143) stock is a Hold with a HK$0.50 price target. To see the full list of analyst forecasts on Link-Asia International Medtech Group Ltd. stock, see the HK:1143 Stock Forecast page.
China Energy Storage Technology Development Limited announced the lapse of its Joint Placing Agreement due to unmet conditions by the deadline, resulting in the cessation of the planned Placing. The company assured stakeholders that this development will not adversely affect its operational or financial standing.
The most recent analyst rating on (HK:1143) stock is a Hold with a HK$0.50 price target. To see the full list of analyst forecasts on Link-Asia International Medtech Group Ltd. stock, see the HK:1143 Stock Forecast page.
China Energy Storage Technology Development Limited has announced a board meeting scheduled for August 29, 2025. The meeting will focus on approving the interim results for the first half of 2025, considering the payment of an interim dividend, and addressing other business matters. This announcement signifies the company’s ongoing commitment to transparency and shareholder engagement, potentially impacting its market positioning and stakeholder relations.
China Energy Storage Technology Development Limited has announced a further extension of the Long Stop Date for the placement of new shares under a general mandate. The extension, now set to 19 August 2025, allows additional time for fulfilling conditions precedent in the Joint Placing Agreement. This move is seen as commercially reasonable and in the interest of the company and its shareholders, although the completion of the placing remains uncertain.
China Energy Storage Technology Development Limited has announced a change in its executive leadership. Ms. Lin Xiaoshan has resigned from her position as executive director to focus on other business commitments, and Ms. Wu Jingjing has been appointed as her successor. Ms. Wu brings over a decade of experience in corporate publicity planning and marketing management, which is expected to enhance the company’s strategic communications and market presence. Her appointment is anticipated to support the company’s growth and strengthen its industry positioning.
China Energy Storage Technology Development Limited, formerly known as Link-Asia International MedTech Group Ltd., has announced its updated list of directors and their roles within the company. The board comprises executive directors, including Mr. Lin Dailian as Chairman, and independent non-executive directors. The announcement details the composition of three key board committees, highlighting the leadership and membership roles of the directors. This restructuring could potentially impact the company’s governance and strategic direction, influencing its positioning in the energy storage sector.
China Energy Storage Technology Development Limited has announced the establishment of a new wholly-owned subsidiary, Telefield (Cambodia) Electronic Company Limited (TCE), in Cambodia. This strategic move aims to capitalize on tax benefits for importing materials from China and exporting products to the US, with an investment of approximately USD 5 million planned over the next 12 months. The company expects mass production to commence by the end of 2025, potentially expanding its customer base in the US market.
China Energy Storage Technology Development Limited has announced an extension of the Long Stop Date for the placing of new shares under a general mandate. The extension, agreed upon with the Joint Placing Agent, moves the deadline from July 15, 2025, to July 29, 2025, allowing more time to fulfill conditions precedent in the Joint Placing Agreement. The directors believe the extension is commercially reasonable and in the best interests of the company and its shareholders. The placing may still be subject to conditions, and stakeholders are advised to exercise caution.
Link-Asia International Medtech Group Ltd. has announced a placing agreement to issue up to 44,856,000 new shares, representing about 20% of its current share capital, at a price of HK$0.33 per share. This move is expected to raise approximately HK$14.5 million in net proceeds, which the company plans to use for acquiring energy storage products. The shares will be placed with at least six independent third-party investors, and the transaction is subject to certain conditions being met, indicating potential implications for the company’s financial strategy and market positioning.
China Energy Storage Technology Development Limited announced the lapse of its proposed change in board lot size, which was initially intended to increase from 4,000 shares to 8,000 shares. This decision follows the lapse of the Rights Issue, indicating a strategic shift that may impact the company’s market operations and investor relations.